Related Experiment Video
Updated: Jul 15, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Striking back at the activator: how IkappaB kinase terminates antigen receptor responses
Michael Hinz1, Claus Scheidereit
1Max Delbrück Center for Molecular Medicine, 13092 Berlin, Germany.
Insights
TCR signaling activates NF-kappaB via IKK. IKKbeta phosphorylates Bcl10, disrupting the CBM complex to terminate signaling and prevent immune dysregulation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- T cell receptor (TCR) signaling activates Nuclear Factor kappa B (NF-kappaB) through IkappaB kinases (IKK).
- NF-kappaB controls lymphocyte functions, necessitating precise temporal regulation of its activation.
- Mechanisms for terminating TCR-induced signaling remain less understood compared to activation pathways.
Purpose of the Study:
- To investigate the negative feedback mechanisms regulating TCR-induced NF-kappaB pathway termination.
- To elucidate the role of the scaffold protein Bcl10 in signaling termination.
Main Methods:
- Investigated the interaction between IKK and the CBM complex components (CARMA1, Bcl10, Malt1).
- Analyzed the phosphorylation status of Bcl10 by IKKbeta.
- Examined the effect of Bcl10 phosphorylation on CBM complex stability and NF-kappaB activation.
Main Results:
- Bcl10 serves as a negative feedback substrate for IKK.
- IKKbeta initially promotes CBM complex formation for activation, then phosphorylates Bcl10 to disrupt the complex and terminate signaling.
- IKK-mediated Bcl10 phosphorylation also targets it for degradation via the ubiquitin-proteasome system.
Conclusions:
- Negative feedback mechanisms are intrinsic to the termination of TCR-induced NF-kappaB signaling.
- The scaffold protein Bcl10 plays a critical role in both initiating and terminating TCR signaling through IKK-mediated phosphorylation.
Abstract:
Antigen recognition by the T cell receptor (TCR) elicits several intracellular signaling cascades, one of which activates the transcription factor NF-kappaB through IkappaB kinases (IKK). NF-kappaB regulates lymphocyte differentiation, proliferation, and apoptosis; thus, tight temporal control of its activation is required to prevent harmful immune cell dysregulation. Although considerable insight into the IKK and NF-kappaB activation process has emerged, less is known about the temporal regulation and termination of immunoreceptor signaling. Two recent studies have revealed that the scaffold protein Bcl10--which, together with CARMA1 and Malt1, forms the TCR-induced IKK-activating CBM complex--is a negative feedback substrate for IKK. IKKbeta initially contributes to CBM formation--which is required for full IKK activation--and then, through carboxyl-terminal Bcl10 phosphorylation, disrupts this structure to terminate signaling. IKK triggers Bcl10 degradation by the ubiquitin-proteasome system through phosphorylation of Bcl10 at other sites. Thus, inactivation through negative feedback mechanisms is an intrinsic property of the TCR-induced NF-kappaB pathway.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

